How can the results from BRIDGE Health be incorporated to the work of HBM4EU? Deliverable Report AD 11.1

The DG Santé funded research project BRidging Information and Data Generation for Evidencebased Health policy and research (BRIDGE Health1 ) started in May 2015 and will run until October 2017. The project was designed to merge knowledge from different existing EU projects in domains of population and health system monitoring, indicator development, health examination surveys, environment and health, population injury and disease registries, as well as clinical and administrative health data collection systems and methods of health systems monitoring and evaluation to generate the basis for a long-term EU wide infrastructure and research network to build and maintain a high quality and representative European Health information system. Besides this, BRIDGE Health deliberately did preparatory work for HBM4EU in terms of problem identification, gap analysis and the development of blueprint for use of HBM in the field of health information and public health policies. In 2017 the European Human Biomonitoring Initiative – HBM4EU2 (HBM4EU) project was established as a joint effort to advance human biomonitoring (HBM) in Europe in order to provide better evidence of the actual exposure of citizens to chemicals. HBM4EU works towards a robust interpretation of human biomonitoring data and the possible impact of chemical exposure on human health, using the most up to date scientific tools and the key objectives are: Harmonising procedures for human biomonitoring across the 26 participating countries, to provide policy makers with comparable data on human internal exposure to chemicals and mixtures of chemicals at EU level; Linking data on internal exposure to chemicals to aggregate external exposure and identifying exposure pathways and upstream sources; Generating scientific evidence on the causal links between human exposure to chemicals and health outcomes; Providing the most relevant tools to detect emerging chemicals and to identify the chemical mixtures of highest concern; Adapting chemical risk assessment methodologies to use human biomonitoring data and account for the contribution of multiple external exposure pathways to the total chemical body burden; Feeding information on exposure pathways into the design of targeted policy measures to reduce exposure. HBM4EU builds directly on and expands the work of the FP7 and Life+ funded HBM pilot projects COPHES and DEMOCOPHES3 to establish a long-term sustainable EU wide HBM system as a science and policy tool. Furthermore, it explicitly builds on the results of BRIDGE Health, which has a number of similar topics in order to make best use of resources and to prevent double work. In the framework of the transition from BRIDGE Health to HBM4EU, this report takes a close look on the specific results of each BRIDGE Health Work Package (WP), with the objective to bring these in accordance with the progress of the HBM4EU project